Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01385020Phase 4Completed
Phase 4, randomised, open-label trial of LipoCol Forte in hypercholesterolemia, sponsored by National Taiwan University Hospital. Primary endpoints: Pharmacokinetic parameters of lovastatin at 1 week and Pharmacokinetic parameters of lovastatin acid at 1 week. Started Jul 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01385020.